CHRISTUS Health IRB
The CHRISTUS Health Institutional Review Board (IRB) is here to protect the rights and welfare of subjects participating in research. Under FDA regulations, an IRB is an appropriately constituted group that has been formally designated to review and monitor biomedical research involving human subjects. In accordance with FDA regulations, an IRB has the authority to approve, require modifications in (to secure approval), or disapprove research. The involvement of human subjects in research is not permitted until the IRB has approved the research protocol.
The CHRISTUS Health IRB abides by the CHRISTUS Health policies and procedures, Catholic Church Directives, Belmont Report, Food and Drug Administration, and the Office of Human Research Protections federal regulations.
- Initial Protocol and Informed Consent form Review
- Annual Continuing Review of Protocol and Informed Consent
- Protocol and Informed Consent form Amendment Review
- Exempt and Expedited Research Review
- Quality Improvement (QI) and Quality Assurance (QA) Review
CHRISTUS Health IRB will convene for a monthly meeting on the third Thursday of each month from 8 a.m. - 10 a.m. Research submissions are due 2 weeks prior to the meeting. For meeting calendar, click here.
The OHSRPP Team
For assistance, the Office of Human Subjects Research Protection staff are available Monday – Friday from 8:00am until 5:00pm CST.